The global Automated Breast Ultrasound System (Abus) Market was valued at USD 1.7 Billion in 2022 and is projected to reach USD 5.11 Billion by 2032, with a compound annual growth rate (CAGR) of 13% during the forecast period. The main drivers of market revenue growth are the increasing prevalence of breast cancer worldwide and the growing demand for fast and accurate diagnoses. According to the World Health Organization (WHO), breast cancer is the most common cancer among women globally, and it is expected that around 2.3 million new cases will be diagnosed in 2020 alone.
The market's revenue growth is attributed to the rising adoption of ABUS systems as a reliable screening tool and the growing recognition of the importance of breast cancer screening. Compared to traditional mammography, ABUS devices are designed to offer a more comprehensive and precise image of breast tissue, particularly in women with dense breasts. Studies have shown that the use of ABUS systems improves cancer detection rates while reducing the occurrence of false-positive findings.
Get a sample of the report @ https://www.reportsanddata.com/download-free-sample/3936
Competitive Landscape:
Some major companies included in the global ABUS market report are:
- General Electric Company
- Siemens Healthcare GmbH
- Hitachi, Ltd.
- Koninklijke Philips N.V.
- Fujifilm Holdings Corporation
- SonoCine Inc.
- Delphinus Medical Technologies, Inc.
- Hologic, Inc.
- QT Ultrasound LLC
To know more about the report @ https://www.reportsanddata.com/report-detail/automated-breast-ultrasound-system-abus-market
Driving Factors of Automated Breast Ultrasound System (ABUS) Market:
- Increasing Prevalence of Breast Cancer: The rising incidence of breast cancer globally is a major driving factor for the ABUS market. As breast cancer continues to be the most common cancer among women, the demand for advanced diagnostic tools such as ABUS is expected to grow.
- Growing Awareness and Importance of Early Detection: There is a growing awareness among women about the importance of early detection and screening for breast cancer. ABUS systems provide a reliable and effective screening tool, leading to an increased demand for these systems.
- Superior Imaging Capabilities: ABUS devices offer improved imaging capabilities compared to conventional mammography, especially for women with dense breast tissue. The ability to provide more thorough and precise images of breast tissue enhances the detection and diagnosis of breast cancer, driving the adoption of ABUS systems.
- Reduced False-Positive Results: ABUS systems have demonstrated a lower rate of false-positive findings compared to other imaging modalities. This factor contributes to increased confidence among healthcare professionals and patients, leading to a higher adoption rate of ABUS systems.
Restraints of Automated Breast Ultrasound System (ABUS) Market:
- High Cost: The cost of ABUS systems is relatively higher compared to traditional mammography. This can limit the adoption of ABUS systems, especially in resource-constrained settings or regions with limited healthcare budgets.
- Limited Availability and Accessibility: ABUS systems may not be readily available in all healthcare facilities, particularly in developing regions. The limited accessibility to ABUS systems can impede their widespread adoption and usage.
- Lack of Skilled Personnel: Operating and interpreting ABUS images require specialized training and expertise. The shortage of trained personnel who can effectively utilize ABUS systems may hinder their widespread implementation.
- Regulatory Challenges: ABUS systems are subject to regulatory approvals and compliances in different countries. Navigating through regulatory processes and obtaining necessary approvals can pose challenges for manufacturers, potentially affecting market growth.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/3936
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Browse More Reports:
Alpha-Adrenoreceptor Antagonists Market
Titanium Dental Implants Market
Animal Pharm Antibiotics Market
